|
- 2017
T细胞CD3ζ 3'-UTR区域突变类型的特点
|
Abstract:
摘要 目的分析CD3ζ 3'-UTR区域的突变/SNP的类型情况,深入了解中国汉族健康人CD3ζ 3'-UTR的突变/SNP特点.方法:利用RT-PCR,T载体克隆以及核苷酸测序等技术分析20例健康人外周血单个核细胞中CD3ζ 3'-UTR突变/SNP突变类型等情况.结果:20例健康人外周血单个核细胞中CD3ζ 3'-UTR 区域共检出21种突变/SNP.CD3ζ 3'-UTR区域的腺嘌呤、胸腺嘧啶、鸟嘌呤和胞嘧啶均发生不同频率的突变,依次为37.36%,16.48%,40.66%和5.50%.腺嘌呤的突变频率显著高于胸腺嘧啶和胞嘧啶(P均为0.00);鸟嘌呤的突变频率显著高于胸腺嘧啶和胞嘧啶(P均为0.00);胸腺嘧啶的突变频率显著高于胞嘧啶(P=0.02).CD3ζ 3'-UTR区域缺失、转换和颠换突变检出频率依次为21.98%,35.16%和42.86%,缺失突变的频率显著低于转换和置换突变(P=0.05,P=0.02),转换/颠换比值为0.82.结论:首次报道中国健康人外周血单个核细胞中CD3ζ 3'-UTR 区域突变类型特点,T>C转换突变在中国汉族健康人CD3ζ 3'-UTR 区域的高频出现影响转换/颠换比.
[1] | LI Y Q, LIN C, LI B. T cell receptor and its application[M]∥CHEN S,LI YQ. Significance and Application of TCRζ Gene Analysis. Beijing: People's Medical Publishing House, 2009: 2-3. |
[2] | 沈 琦,陈少华,杨力建,等. 淋巴细胞白血病患者CD3基因表达模式的变化[J]. 暨南大学学报(自然科学与医学版),2011, 32(2):131-135. |
[3] | SHEN Q, CHEN S H, YANG L J, et al. Changes of CD3 gene expression pattern in patients with lymphoid malignancies[J].Journal of Jinan University (Natural Science & Medicine Edition), 2011, 32(2):131-135. |
[4] | NAMBIAR M P, ENYEDY E J, WARKE V G, et al. Polymorphisms/mutations of TCR-zeta-chain promoter and 3' untranslated region and selective expression of TCR zeta-chain with an alternatively spliced 3' untranslated region in patients with systemic lupus erythematosus[J]. Autoimmun, 2001, 16(2):133-142. |
[5] | TSUZAKA K, NOZAKI K, KUMZAWAY C, et al. TCR zeta mRNA splice variant forms observed in the peripheral blood T cells from systemic lupus erythematosus patients[J].Springer Semin Immunopathol, 2006, 28(2):185-193. |
[6] | GORMAN C L, RUSSELL A I, ZHANG Z, et al. Polymorphisms in the CD3Z gene influence TCRzeta expression in systemic lupus erythematosus patients and healthy controls[J]. Immunol,2008,180(2):1060-1070. |
[7] | WARCHOL T, PIOTROWISK P, LIANERI M, et al. The CD3Z 844 T > A polymorphism within the 3 '-UTR of CD3Z confers increased risk of incidence of systemic lupus erythematosus[J]. Tissue Antigens,2009, 74(1):68-72. |
[8] | ZHA X F, YAN X, SHEN Q, et al. Alternative expression of TCRζ related genes in patients with chronic myeloid leukemia[J]. Journal Of Hematology & Oncology, 2012,5(1):74-85. |
[9] | GREGORY T R. Insertion-deletion biases and the evolution of genome size[J]. Gene, 2004,324(1):15-34. |
[10] | 陈建军,王 瑛.植物基因组大小进化的研究进展[J].遗传,2009,31(5):464-470. |
[11] | CHEN J J,WANG Y. Advances in plant genome size evolution[J]. Heredity, 2009,31 (5): 464-470. |
[12] | TAYLOR J, TYEKUTHEVA S, ZODY M, et al. Strong and weak male mutation bias at different sites in the primate genomes: insights from the human-chimpanzee comparison[J].Mol Biol Evol, 2006, 23(3):565-73. |
[13] | MOORE PS, BEGHELLI S, ZAMBONI G, et al. Genetic abnormalities in pancreatic cancer[J]. Mol Cancer, 2003, 2(1):7. |
[14] | HAINAUT P, PFEIFER G P. Somatic TP53 Mutations in the Era of Genome Sequencing[J]. Cold Spring Harb Perspect Med, 2016,6(11):a026179. |
[15] | DUCHENE S, HO S Y, HOLMES E C. Declining transition/transversion ratios through time reveal limitations to the accuracy of nucleotide substitution models[J].BMC Evol Biol, 2015, 15(1):36-45. |
[16] | IIDA A, SAITO S, SEKINE A, et al. Catalog of 46 single-nucleotide polymorphisms (SNP) in microsomal glutathione-S-transferase-1 (MGST1) gene[J]. Human Genet, 2001, 46(10):590-594. |
[17] | 李扬秋,林 晨,李 萡. T细胞受体的研究和应用[M]∥陈思,李扬秋.TCRζ基因分析的意义和应用.北京:人民卫生出版社,2009:2-3. |
[18] | LI B, GUO L X, ZHANG Y K, et al. Molecular alterations in the TCR signaling pathway in patients with aplastic anemia[J]. Journal Of Hematology & Oncology, 2016, 9(1):32. |
[19] | MASSEY S E. Genetic code evolution reveals the neutral emergence of mutational robustness, and information as an evolutionary constraint.Life (Basel), 2015,5(2):1301-1332. |
[20] | STOLTFUS A, NORRIS R W. On the Causes of Evolutionary Transition:Transversion Bias[J]. Mol Biol Evol, 2016, 33(3):595-602. |